Roivant Sciences Long Term Debt

The latest long-term debt for ROIV is $96M as of March 2026. That compares with $180M in the prior-year period — down 46.7% year over year. Investors often review this figure alongside Roivant Sciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, ROIV's long-term debt moved from $180M to $96M — a 46.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Roivant Sciences's operating scale or balance-sheet position.

A long-term debt figure of $96M for ROIV is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ROIV's long-term debt ($96M), review year-over-year change from $180M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.